Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative N-acetylcysteine during laparoscopic bariatric surgery
2008-001677-15Phase 4Terminated
- Sponsor
- King's College Hospital
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of acetylcysteine in metabolic dysfunction-associated steatotic liver disease (MASLD) and nonalcoholic fatty liver disease (NAFLD) (2 arms), sponsored by King's College Hospital. Primary endpoints: Change in AST and Change in ALT. Started May 2008; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)nonalcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on 2008-001677-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001677-15.